Curexo Inc
KOSDAQ:060280
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5 830
19 140
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Curexo Inc
Cash & Cash Equivalents
Curexo Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Curexo Inc
KOSDAQ:060280
|
Cash & Cash Equivalents
₩5.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
29%
|
CAGR 10-Years
-8%
|
|
|
Dong Suh Companies Inc
KRX:026960
|
Cash & Cash Equivalents
₩35.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-6%
|
|
|
H
|
Hyundai Green Food Co Ltd
KRX:005440
|
Cash & Cash Equivalents
₩257.9B
|
CAGR 3-Years
78%
|
CAGR 5-Years
41%
|
CAGR 10-Years
16%
|
|
|
Hyundai Corporation Holdings Co Ltd
KRX:227840
|
Cash & Cash Equivalents
₩44.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
C
|
CJ Freshway Corp
KOSDAQ:051500
|
Cash & Cash Equivalents
₩65.8B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
24%
|
CAGR 10-Years
18%
|
|
Curexo Inc
Glance View
CUREXO, Inc. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul and currently employs 92 full-time employees. The company went IPO on 2002-07-03. The firm operates its business through two segments. The Trading Business segment sells raw materials of instant noodles and fermented milk. The Medical Device segment manufactures TSolution One which is an orthopedic surgical robot, morning walk which is a rehabilitation robot, and other medical devices.
See Also
What is Curexo Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
5.5B
KRW
Based on the financial report for Sep 30, 2024, Curexo Inc's Cash & Cash Equivalents amounts to 5.5B KRW.
What is Curexo Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-8%
Over the last year, the Cash & Cash Equivalents growth was 36%. The average annual Cash & Cash Equivalents growth rates for Curexo Inc have been 26% over the past three years , 29% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet